31 results
Lower Extremity Venous Thrombosis - Management and Anatomy

Deep - Superficial - Active Bleeding

#LowerExtremity #Veins #Venous #Thrombosis
Extremity Venous Thrombosis ... - Management and ... Veins #Venous #Thrombosis ... Superficial #Deep #VTE #DVT ... #Hematology #Management
Upper Extremity Venous Thrombosis - Management and Anatomy

Deep - Superficial - Catheter Associated

#UpperExtremity #Veins #Venous #Thrombosis
Extremity Venous Thrombosis ... - Management and ... Veins #Venous #Thrombosis ... Superficial #Deep #VTE #DVT ... #Hematology #Management
Treatment Algorithm for First Time DVT
 • Provoked
 • Unprovoked
 • Active Malignancy

By Carlin Rooke, MD.

#DVT
for First Time DVT ... #DVT #Treatment ... #Algorithm #management ... #hematology #VTE ... #thrombosis #venous
Causes of Arterial and Venous Thrombosis - Differential Diagnosis Framework

STRUCTURAL:
 - PFO: paradoxical emboli
 - Popliteal
Causes of Arterial ... and Venous Thrombosis ... artery aneurysm: Causes ... compression and DVT ... Diagnosis #clots #hematology
Causes of Breakthrough/Extension of Thrombosis and Management Algorithm

#Anticoagulation #Breakthrough #Thrombosis #Algorithm #Extension #VTE #DVT #Hematology #Management
Causes of Breakthrough ... /Extension of Thrombosis ... and Management ... Extension #VTE #DVT ... #Hematology #Management
Clotmaster Consensus 2019: Duration of Therapy for Venous Thromboembolic Disease
 • Superficial Venous Thrombosis
 • Upper
Upper Extremity DVT ... Provoked first DVT ... syndrome - ... anticoagulation #duration #management ... #DVT #hematology
Recurrent / Breakthrough DVT During Anticoagulation

Subtherapeutic Anticoagulation
Hypercoagulable State 
 - Antithrombin deficiency 
 - Hypercoagulability ot
/ Breakthrough DVT ... Structural - Pelvic masses ... - May-Thurner syndrome ... Breakthrough #Recurrent #DVT ... anticoagulation #hematology
2019 EULAR recommendations for thrombosis in (Antiphospholipid Syndrome) APS
Venous Thrombosis - Arterial Thrombosis
INR Target
Duration
Recurrence

Dr. Laurent ARNAUD
Antiphospholipid Syndrome ... Antiphospholipid #Syndrome ... #APS #management ... EULAR2019 #guidelines #rheumatology ... #hematology #treatment
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
cancer-associated thrombosis ... DVT = deep vein ... thrombosis; PE = ... Anticoagulation #Management ... #Hematology #Oncology
Approach to Thrombotic Microangiopathy (TMA) - Differential Diagnosis and Management Algorithm

Suspected TMA: Unexplained thrombocytopenia + MAHA
Approach to Thrombotic ... Diagnosis and Management ... aPTT normal • DAT ... MatthewHoMD #Thrombotic ... #Algorithm #hematology